Mammography

The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.

Latest News

Study Reveals Disparities in Use of Follow-Up Diagnostic Services After Abnormal Mammography Findings

By Jeff Hall

February 18th 2025

Black, Hispanic, and Asian women were over 25 percent less likely than White women to have same-day follow-up diagnostic service after abnormal findings on screening mammography exams, according to a new study involving over one million patients.

How Does Hormonal Regulation Impact Background Parenchymal Enhancement on Contrast-Enhanced Mammography?

By Jeff Hall

February 12th 2025

Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection

By Jeff Hall

February 5th 2025

Can Mammography-Based AI Enhance Breast MRI Use in Patients with Intermediate Risk for Breast Cancer?

By Jeff Hall

February 4th 2025

Can AI Bolster Breast Cancer Detection in DBT Screening?

By Jeff Hall

January 16th 2025

Latest CME Events & Activities

2025 GU Satellite Symposia in San Francisco

February 13-14, 2025

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

26th Annual International Lung Cancer Congress®

July 25-26, 2025

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure